The FDA Proposal for Regulating Laboratory Diagnostics Could Improve Patient Care
By Rachel Sachs [Note: I am very pleased to have had the opportunity to write a response to a recent commentary posted on the Hastings Center Bioethics Forum about the FDA’s proposed draft guidance for the regulation of laboratory-developed tests (LDTs), an issue I have previously written about for this blog. My response, which is posted here…